P2Y1, P2Y2, P2Y4, and P2Y6 receptors are coupled to Rho and Rho kinase activation in vascular myocytes

被引:89
作者
Sauzeau, V
Le Jeune, H
Toumaniantz, CC
Vaillant, N
Gadeau, AP
Desgranges, C
Scalbert, E
Chardin, P
Pacaud, P
Loirand, G
机构
[1] Fac Sci, INSERM, U533, Lab Physiol Cellulaire & Mol, F-44322 Nantes 3, France
[2] INSERM, U441, F-33600 Pessac, France
[3] Inst Rech Int Servier, F-92415 Courbevoie, France
[4] CNRS, Inst Pharmacol Mol & Cellulaire, Unite Propre Rech 411, F-06560 Sophia Antipolis, France
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2000年 / 278卷 / 06期
关键词
guanosine 5 '-triphosphate-binding proteins; extracellular nucleotides; vascular tone;
D O I
10.1152/ajpheart.2000.278.6.H1751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the cardiovascular system, activation of ionotropic (P2X receptors) and metabotropic (P2Y receptors) P2 nucleotide receptors exerts potent and various responses including vasodilation, vasoconstriction, and vascular smooth muscle cell proliferation. Here we examined the involvement of the small GTPase RhoA in P2Y receptor-mediated effects in vascular myocytes. Stimulation of cultured aortic myocytes with P2Y receptor agonists induced an increase in the amount of membrane-bound RhoA and stimulated actin cytoskeleton organization. P2Y receptor agonist-induced actin stress fiber formation was inhibited by C3 exoenzyme and the Rho kinase inhibitor Y-27632. Stimulation of actin cytoskeleton organization by extracellular nucleotides was also abolished in aortic myocytes expressing a dominant negative form of RhoA. Extracellular nucleotides induced contraction and Y-27632-sensitive Ca2+ sensitization in aortic rings. Transfection of Swiss 3T3 cells with P2Y receptors showed that Rho kinase-dependent actin stress fiber organization was induced in cells expressing P2Y(1), P2Y(2), P2Y(4), or P2Y(6) receptor subtypes. Our data demonstrate that P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptor subtypes are coupled to activation of RhoA and subsequently to Rho-dependent signaling pathways.
引用
收藏
页码:H1751 / H1761
页数:11
相关论文
共 34 条
[1]  
DALZIEL HH, 1994, PHARMACOL REV, V46, P449
[2]   SIGNAL-TRANSDUCTION VIA P2-PURINERGIC RECEPTORS FOR EXTRACELLULAR ATP AND OTHER NUCLEOTIDES [J].
DUBYAK, GR ;
ELMOATASSIM, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :C577-C606
[3]   Extracellular ATP: A growth factor for vascular smooth muscle cells [J].
Erlinge, D .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1998, 31 (01) :1-8
[4]   Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR [J].
Erlinge, D ;
Hou, M ;
Webb, TE ;
Barnard, EA ;
Möller, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :864-870
[5]   A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho [J].
Fukuhara, S ;
Murga, C ;
Zohar, M ;
Igishi, T ;
Gutkind, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (09) :5868-5879
[6]   Differential involvement of Gα12 and Gα13 in receptor-mediated stress fiber formation [J].
Gohla, A ;
Offermanns, S ;
Wilkie, TM ;
Schultz, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :17901-17907
[7]   Role of guanine nucleotide-binding proteins ras-family or trimeric proteins or both in Ca2+ sensitization of smooth muscle [J].
Gong, MC ;
Iizuka, K ;
Nixon, G ;
Browne, JP ;
Hall, A ;
Eccleston, JF ;
Sugai, M ;
Kobayashi, S ;
Somlyo, AV ;
Somlyo, AP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) :1340-1345
[8]  
Gong MC, 1997, J BIOL CHEM, V272, P10704
[9]   Effect of extracellular ATP on cytosolic Ca2+ concentration in rat pulmonary artery myocytes [J].
Guibert, C ;
Pacaud, P ;
Loirand, G ;
Marthan, R ;
Savineau, JP .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1996, 271 (03) :L450-L458
[10]   Dependence of P2-nucleotide receptor agonist-mediated endothelium-independent relaxation on ectonucleotidase activity and A2A-receptors in rat portal vein [J].
Guibert, C ;
Loirand, G ;
Vigne, P ;
Savineau, JP ;
Pacaud, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (08) :1732-1740